Network Meta-Analysis of Randomized Trials in Relapsed/Refractory Multiple Myeloma: Relative Efficacy for Patients Who Are Lenalidomide-Refractory

被引：0
|
作者：
Kastritis, Efstathios [1 ]
Harvey, Rebecca [2 ]
Cranmer, Holly [3 ]
Bianco, Martina [4 ]
Fenu, Elisabetta [5 ]
La Porte, Charles [6 ]
Ramasamy, Karthik [7 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Cabourn Stat Ltd, Warrington, England
[3] Cranmer Consultancy Ltd, Sheffield, England
[4] Menarini Ric, Pomezia, Italy
[5] Menarini GmbH, Zurich, Switzerland
[6] Menarini Stemline Therapeut, New York, NY USA
[7] Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Catalano, Lucio
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S5 - S6
  • [32] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Nappi, Davide
    Pareto, Anna Emanuele
    Di Perna, Maria
    Ronconi, Sonia
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E358 - E359
  • [33] A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma After Lenalidomide Exposure
    Davies, Faith E.
    Leleu, Xavier
    Vogel, Prisca
    Dhanasiri, Sujith
    Le Nouveau, Pauline
    Weisel, Katja
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 829 - +
  • [34] Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients
    van Beurden-Tan, Chrissy H. Y.
    Franken, Margreet
    Blommestein, Hedwig
    Uyl-de Groot, Carin
    Sonneveld, Pieter
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E144 - E144
  • [35] Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients
    Van Beurden-Tan, Chrissy H. Y.
    Franken, Margreet
    Blommestein, Hedwig
    Uyl-De Groot, Carin A.
    Sonneveld, Pieter
    BLOOD, 2016, 128 (22)
  • [36] Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
    Plesner, Torben
    Arkenau, Hendrik-Tobias
    Lokhorst, Henk M.
    Gimsing, Peter
    Krejcik, Jakub
    Lemech, Charlotte
    Minnema, Monique C.
    Lassen, Ulrik
    Laubach, Jacob P.
    Ahmadi, Tahamtan
    Yeh, Howard
    Guckert, Mary E.
    Feng, Huaibao
    Brun, Nikolai Constantin
    Lisby, Steen
    Basse, Linda
    Palumbo, Antonio
    Richardson, Paul G.
    BLOOD, 2014, 124 (21)
  • [37] SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA
    Plesner, T.
    Arkenau, H. T.
    Lokhorst, H. M.
    Gimsing, P.
    Krejcik, J.
    Lemech, C.
    Minnema, M. C.
    Lassen, U.
    Ahmadi, T.
    Yeh, H.
    Guckert, M.
    Brun, N. C.
    Lisby, S.
    Basse, L.
    Palumbo, A.
    Richardson, P. G.
    HAEMATOLOGICA, 2014, 99 : 104 - 104
  • [38] A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis
    Dimopoulos, Meletios Athanasios
    Kaufman, Jonathan L.
    White, Darrell
    Cook, Gordon
    Rizzo, Maria
    Xu, Yingxin
    Fahrbach, Kyle
    Gaudig, Maren
    Slavcev, Mary
    Dearden, Lindsay
    Lam, Annette
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (03): : 163 - +
  • [39] A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis
    Weisel, Katja
    Sonneveld, Pieter
    Spencer, Andrew
    Beksac, Meral
    Rizzo, Maria
    Xu, Yingxin
    Fahrbach, Kyle
    Gaudig, Maren
    Slavcev, Mary
    Dearden, Lindsay
    Lam, Annette
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 151 - 162
  • [40] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    Martinelli, Giovanni
    BLOOD, 2021, 138
12345